Literature DB >> 33183844

The COVID-19 Pandemic Changes the Scientific Publication System.

Rafael Dal-Ré1, Ferrán Morell2.   

Abstract

Year:  2020        PMID： 33183844      PMCID： PMC7577898          DOI： 10.1016/j.arbres.2020.10.010

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  9 in total

1.  The COVID-19 Pandemic and the JAMA Network.

Authors:  Michael Berkwits; Annette Flanagin; Howard Bauchner; Phil B Fontanarosa
Journal:  JAMA       Date:  2020-09-22       Impact factor: 56.272

Review 2.  Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches.

Authors:  Rafael Dal-Ré
Journal:  Expert Rev Clin Pharmacol       Date:  2020-09-03       Impact factor: 5.045

3.  An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).

Authors:  Nicole Shu Ling Yeo-Teh; Bor Luen Tang
Journal:  Account Res       Date:  2020-06-23       Impact factor: 2.622

Review 4.  Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.

Authors:  Adriani Nikolakopoulou; Dimitris Mavridis; Toshi A Furukawa; Andrea Cipriani; Andrea C Tricco; Sharon E Straus; George C M Siontis; Matthias Egger; Georgia Salanti
Journal:  BMJ       Date:  2018-02-28

5.  Reasons for and time to retraction of genetics articles published between 1970 and 2018.

Authors:  Rafael Dal-Ré; Carmen Ayuso
Journal:  J Med Genet       Date:  2019-07-12       Impact factor: 6.318

6.  Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).

Authors:  Sophie Juul; Emil Eik Nielsen; Joshua Feinberg; Faiza Siddiqui; Caroline Kamp Jørgensen; Emily Barot; Niklas Nielsen; Peter Bentzer; Areti Angeliki Veroniki; Lehana Thabane; Fanlong Bu; Sarah Klingenberg; Christian Gluud; Janus Christian Jakobsen
Journal:  PLoS Med       Date:  2020-09-17       Impact factor: 11.069

7.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

8.  Drug treatments for covid-19: living systematic review and network meta-analysis

Authors:  Reed Ac Siemieniuk; Jessica J Bartoszko; Dena Zeraatkar; Elena Kum; Anila Qasim; Juan Pablo Díaz Martinez; Ariel Izcovich; Francois Lamontagne; Mi Ah Han; Arnav Agarwal; Thomas Agoritsas; Maria Azab; Gonzalo Bravo; Derek K Chu; Rachel Couban; Tahira Devji; Zaira Escamilla; Farid Foroutan; Ya Gao; Long Ge; Maryam Ghadimi; Diane Heels-Ansdell; Kimia Honarmand; Liangying Hou; Quazi Ibrahim; Assem Khamis; Bonnie Lam; Christian Mansilla; Mark Loeb; Anna Miroshnychenko; Maura Marcucci; Shelley L McLeod; Sharhzad Motaghi; Srinivas Murthy; Reem A Mustafa; Hector Pardo-Hernandez; Gabriel Rada; Yamna Rizwan; Pakeezah Saadat; Charlotte Switzer; Lehana Thabane; George Tomlinson; Per O Vandvik; Robin Wm Vernooij; Andrés Viteri-García; Ying Wang; Liang Yao; Yunli Zhao; Gordon H Guyatt; Romina Brignardello-Petersen
Journal:  BMJ       Date:  2020-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.